Anthony H Nguyen

Array ( [id] => 5937355 [patent_doc_number] => 20110212894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'DECELLULARIZATION METHOD FOR SCAFFOLDLESS TISSUE ENGINEERED ARTICULAR CARTILAGE OR NATIVE CARTILAGE TISSUE' [patent_app_type] => utility [patent_app_number] => 13/029325 [patent_app_country] => US [patent_app_date] => 2011-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9647 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212894.pdf [firstpage_image] =>[orig_patent_app_number] => 13029325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7485703 [patent_doc_number] => 20110250589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'BIOMARKERS FOR LUNG DISEASE MONITORING' [patent_app_type] => utility [patent_app_number] => 13/011541 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27658 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250589.pdf [firstpage_image] =>[orig_patent_app_number] => 13011541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950104 [patent_doc_number] => 20130195884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'NOVEL MODULATORS OF TRAIL SIGNALLING' [patent_app_type] => utility [patent_app_number] => 13/519955 [patent_app_country] => US [patent_app_date] => 2010-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 36231 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062131 [patent_doc_number] => 20110200582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM' [patent_app_type] => utility [patent_app_number] => 12/974906 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63519 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200582.pdf [firstpage_image] =>[orig_patent_app_number] => 12974906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212428 [patent_doc_number] => 20110135728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR EXTENDED RELEASE OF POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/963520 [patent_app_country] => US [patent_app_date] => 2010-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18805 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135728.pdf [firstpage_image] =>[orig_patent_app_number] => 12963520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11388737 [patent_doc_number] => 09549968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given target' [patent_app_type] => utility [patent_app_number] => 13/514133 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 28 [patent_no_of_words] => 29445 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8240856 [patent_doc_number] => 20120149591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'IN VITRO PEPTIDE EXPRESSION LIBRARY' [patent_app_type] => utility [patent_app_number] => 12/909420 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19528 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12909420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10188330 [patent_doc_number] => 09217743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-22 [patent_title] => 'Screening method utilizing thalidomide-targeting factor' [patent_app_type] => utility [patent_app_number] => 13/498067 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 11912 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196777 [patent_doc_number] => 20110028535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'OLIGONUCLEOTIDES-TRANSFERRING PREPARATIONS' [patent_app_type] => utility [patent_app_number] => 12/904054 [patent_app_country] => US [patent_app_date] => 2010-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13787 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028535.pdf [firstpage_image] =>[orig_patent_app_number] => 12904054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195611 [patent_doc_number] => 20110027366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'SKIN EQUIVALENT CULTURE' [patent_app_type] => utility [patent_app_number] => 12/902710 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13825 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027366.pdf [firstpage_image] =>[orig_patent_app_number] => 12902710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125353 [patent_doc_number] => 20110086018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'PROTEINASES DESTROY CANCER TUMOR\'S SOLID STRUCTURE AND KILL CANCER CELLS LOCALLY' [patent_app_type] => utility [patent_app_number] => 12/900812 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5844 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086018.pdf [firstpage_image] =>[orig_patent_app_number] => 12900812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10575164 [patent_doc_number] => 09297796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Bent nanowires and related probing of species' [patent_app_type] => utility [patent_app_number] => 13/497852 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 59 [patent_no_of_words] => 26277 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211588 [patent_doc_number] => 20120129918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION' [patent_app_type] => utility [patent_app_number] => 12/886080 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14228 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129918.pdf [firstpage_image] =>[orig_patent_app_number] => 12886080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024936 [patent_doc_number] => 20110053262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'METHODS OF FABRICATING ENHANCED TISSUE-ENGINEERED CARTILAGE' [patent_app_type] => utility [patent_app_number] => 12/874803 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 3645 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053262.pdf [firstpage_image] =>[orig_patent_app_number] => 12874803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8431002 [patent_doc_number] => 20120252877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF TUBEROUS SCLEROSIS COMPLEX' [patent_app_type] => utility [patent_app_number] => 13/390107 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18793 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8198246 [patent_doc_number] => 20120122146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'NANOPARTICLE SCREENING METHODS EMPLOYING INSECTS WITH BLOOD BRAIN BARRIER' [patent_app_type] => utility [patent_app_number] => 13/387094 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4103 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122146.pdf [firstpage_image] =>[orig_patent_app_number] => 13387094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9827714 [patent_doc_number] => 08936942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-20 [patent_title] => 'Polyethyleneglycol-modified lipid compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/852362 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 24741 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12852362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039912 [patent_doc_number] => 20110092961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Artificial cells' [patent_app_type] => utility [patent_app_number] => 12/806008 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 55701 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092961.pdf [firstpage_image] =>[orig_patent_app_number] => 12806008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301472 [patent_doc_number] => 20120184030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'METHODS FOR ESTABLISHING SYMBIOSES' [patent_app_type] => utility [patent_app_number] => 13/384415 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5709 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277898 [patent_doc_number] => 20120171770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'BIOENGINEERED SILK PROTEIN-BASED NUCLEIC ACID DELIVERY SYSTEMS' [patent_app_type] => utility [patent_app_number] => 13/381105 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20477 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381105 [rel_patent_id] =>[rel_patent_doc_number] =>)